Pharmacy Settles Prior Authorization Fraud Allegations for $115,000
New York-based specialty pharmacy allegedly altered documentation, including lab test results, to obtain insurance coverage of expensive drug.
Compliance Lessons for Labs Following Massive Takedown
Here are some steps labs may want to take in the wake of the 2022 National Health Care Fraud Enforcement Action.
Labs on Notice Following Healthcare Fraud Enforcement Action
Danielle H. Tangorre discusses key takeaways for labs from the DOJ’s recent nationwide takedown of $1.2 billion in alleged schemes.
Nationwide Takedown Headlines Busy Enforcement Week
Last week saw a takedown of $1.2B worth of alleged fraud schemes involving labs, genetic testing, and telemedicine.
Diagnostic Lab to Pay Nearly $10 Million to Settle FCA Allegations
BioReference Health LLC and its parent company have agreed to pay $9.85 million to resolve alleged violations of the False Claims Act.